Showing 1 to 12 of 12 results
NHS Approves Cancer Treatment Doubling Survival Rates
The NHS in England has approved enfortumab vedotin with pembrolizumab for over 1,000 bladder cancer patients, a treatment shown to double survival rates compared to chemotherapy in clinical trials, offering extended life expectancy and improved quality of life for those with metastatic disease.
NHS Approves Cancer Treatment Doubling Survival Rates
The NHS in England has approved enfortumab vedotin with pembrolizumab for over 1,000 bladder cancer patients, a treatment shown to double survival rates compared to chemotherapy in clinical trials, offering extended life expectancy and improved quality of life for those with metastatic disease.
Progress
44% Bias Score
UK Cancer Survival Rates Show Wide Disparities, Slowing Progress
A study reveals stark differences in UK cancer survival rates, ranging from 97% for testicular cancer to 4.3% for pancreatic cancer; overall survival has improved since the 1970s but progress has slowed, prompting calls for a national cancer plan to address disparities and improve outcomes.
UK Cancer Survival Rates Show Wide Disparities, Slowing Progress
A study reveals stark differences in UK cancer survival rates, ranging from 97% for testicular cancer to 4.3% for pancreatic cancer; overall survival has improved since the 1970s but progress has slowed, prompting calls for a national cancer plan to address disparities and improve outcomes.
Progress
36% Bias Score
Exercise Improves Colon Cancer Survival by 37%, Study Shows
A Canadian study of 889 colon cancer patients showed that a structured three-year exercise program reduced mortality risk by 37% compared to an educational control group, establishing exercise as a new cancer treatment modality.
Exercise Improves Colon Cancer Survival by 37%, Study Shows
A Canadian study of 889 colon cancer patients showed that a structured three-year exercise program reduced mortality risk by 37% compared to an educational control group, establishing exercise as a new cancer treatment modality.
Progress
40% Bias Score
Exercise Linked to Longer Lifespans for Colon Cancer Patients
A study of nearly 3,000 colon cancer patients found that regular exercise, such as five to six hours of brisk walking weekly, is associated with longer lifespans and a reduced risk of cancer recurrence, offering hope for improved outcomes and potentially extending lifespans to match those without ca...
Exercise Linked to Longer Lifespans for Colon Cancer Patients
A study of nearly 3,000 colon cancer patients found that regular exercise, such as five to six hours of brisk walking weekly, is associated with longer lifespans and a reduced risk of cancer recurrence, offering hope for improved outcomes and potentially extending lifespans to match those without ca...
Progress
40% Bias Score
Physical Fitness Linked to Lower Cancer Mortality Risk
A study of nearly 47,000 cancer patients found that muscular strength and cardiorespiratory fitness were associated with a 31–46% lower risk of death from any cause, with even greater reductions in specific cancer types and stages; this research, published in the British Journal of Sports Medicine, ...
Physical Fitness Linked to Lower Cancer Mortality Risk
A study of nearly 47,000 cancer patients found that muscular strength and cardiorespiratory fitness were associated with a 31–46% lower risk of death from any cause, with even greater reductions in specific cancer types and stages; this research, published in the British Journal of Sports Medicine, ...
Progress
40% Bias Score
Cancer Deaths and Survival Rate Variations Across Europe in 2021
In 2021, cancer caused 1.1 million deaths (21.6% of total) in 29 European countries, with survival rates varying widely; lung cancer was the leading cause, followed by colorectal, prostate, and breast cancers.
Cancer Deaths and Survival Rate Variations Across Europe in 2021
In 2021, cancer caused 1.1 million deaths (21.6% of total) in 29 European countries, with survival rates varying widely; lung cancer was the leading cause, followed by colorectal, prostate, and breast cancers.
Progress
24% Bias Score
Uneven Progress in Cancer Survival Rates Highlights Disparities
A study reveals uneven progress in cancer survival rates over 50 years, with some cancers like melanoma showing 90%+ 10-year survival, while others, including pancreatic, oesophageal, stomach, and lung cancers, lag significantly behind, highlighting disparities in detection and treatment.
Uneven Progress in Cancer Survival Rates Highlights Disparities
A study reveals uneven progress in cancer survival rates over 50 years, with some cancers like melanoma showing 90%+ 10-year survival, while others, including pancreatic, oesophageal, stomach, and lung cancers, lag significantly behind, highlighting disparities in detection and treatment.
Progress
44% Bias Score
Statins Show 39% Reduction in Sepsis Mortality
A study of 12,000 sepsis patients in an Israeli hospital over a decade found that statins reduced the risk of death by 39 percent, with a 14.3 percent death rate within 28 days for statin users versus 23.4 percent for non-users in intensive care.
Statins Show 39% Reduction in Sepsis Mortality
A study of 12,000 sepsis patients in an Israeli hospital over a decade found that statins reduced the risk of death by 39 percent, with a 14.3 percent death rate within 28 days for statin users versus 23.4 percent for non-users in intensive care.
Progress
40% Bias Score
New Bladder Cancer Treatment Offers Hope in Australia
A new combined chemotherapy treatment for bladder cancer is being rolled out in Australian hospitals, offering a significant improvement in survival rates for patients with aggressive cancers in the lining of the bladder who are unsuitable for surgery or immunotherapy, with a 60-69% success rate rep...
New Bladder Cancer Treatment Offers Hope in Australia
A new combined chemotherapy treatment for bladder cancer is being rolled out in Australian hospitals, offering a significant improvement in survival rates for patients with aggressive cancers in the lining of the bladder who are unsuitable for surgery or immunotherapy, with a 60-69% success rate rep...
Progress
40% Bias Score
Exercise Linked to Longer Lifespans for Colon Cancer Patients
A study of nearly 3,000 colon cancer patients found that regular exercise, even 5-6 hours weekly, significantly increased survival rates and reduced cancer recurrence, highlighting the importance of lifestyle choices in improving long-term outcomes.
Exercise Linked to Longer Lifespans for Colon Cancer Patients
A study of nearly 3,000 colon cancer patients found that regular exercise, even 5-6 hours weekly, significantly increased survival rates and reduced cancer recurrence, highlighting the importance of lifestyle choices in improving long-term outcomes.
Progress
24% Bias Score
European Cancer Survival Disparities Highlight Urgent Need for Improved Healthcare
In 2021, cancer caused 1.1 million deaths (21.6% of total deaths) in the European Union, with survival rates varying significantly by cancer type and country due to differences in diagnosis and treatment access. Data from 29 European countries (including 24 EU countries) shows disparities in cancer ...
European Cancer Survival Disparities Highlight Urgent Need for Improved Healthcare
In 2021, cancer caused 1.1 million deaths (21.6% of total deaths) in the European Union, with survival rates varying significantly by cancer type and country due to differences in diagnosis and treatment access. Data from 29 European countries (including 24 EU countries) shows disparities in cancer ...
Progress
16% Bias Score
EU Cancer Survival Rates Vary Widely by Country and Cancer Type
In 2021, cancer was the second leading cause of death in the European Union, with 1.1 million fatalities (21.6% of total deaths); survival rates vary significantly across countries and cancer types due to differences in diagnosis stage, treatment availability, and healthcare system organization.
EU Cancer Survival Rates Vary Widely by Country and Cancer Type
In 2021, cancer was the second leading cause of death in the European Union, with 1.1 million fatalities (21.6% of total deaths); survival rates vary significantly across countries and cancer types due to differences in diagnosis stage, treatment availability, and healthcare system organization.
Progress
16% Bias Score
Showing 1 to 12 of 12 results